1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends

In Vitro Diagnostics (IVD) Market Outlook in China

  • August 2013
  • 81 pages
  • Frost & Sullivan
Report ID: 1610563


Table of Contents

Rising local participants will reshape this market

The IVD market in China presents diversified growth potential for different tiers of participants: domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the high-end market. This research service analyzes the IVD market and provides forecasts and opportunities by understanding the market dynamics and trends. The market can be divided into segments such as clinical chemistry, immunoassay, molecular biology diagnostics, microbiology, coagulation, and hematology. The study covers the period 2007-2016.

Executive Summary

•The Chinese in-vitro diagnostics (IVD) market of $X billion in 2011 is expected to grow at a compound annual growth rate (CAGR) of X percent to reach $X billion in 2016.
•Based on testing principles, the IVD market is segmented into eight, and dominated by four of them, namely, immunoassay, clinical chemistry, hematology, and molecular diagnostics. The four constituted Xpercent of the total market in 2011, standing at $X million.
•Market growth for the traditional segments—Immunoassays, clinical chemistry, hematology, coagulation, and microbiology—are related to the increasing test volume, rather than the higher testing price. The emerging segment is molecular diagnostics, which is experiencing strong growth rates due to its innovation technology. POCT (Point-of-Care-Testing) is at a nascent stage. Although some companies have entered these two segments, they still need time to promote the POCT products and regularize the segment itself. Unlike SMBG (Self-Monitoring of Blood-Glucose), POCT is expected to have stronger growth potential because of policy support.
•The government provides a favorable policy environment for the IVD industry in the form of keeping investment in the primary healthcare system, providing public hospital reforms, encouraging IVD-related technology innovation for local participants, and improving reimbursement policy.
•The IVD market in China presents diversified growth potential for different tiers of competitors: domestic participants gain from the growth momentum for the low-end market, whereas foreign leading manufacturers dominate the high-end market, which is expected to become the new emerging market along with ever-improving localized service to meet various demands.
•Foreign companies dominate the high-end market by leveraging their technical advantage to develop closed-end systems for their automatic analyzers. The mid-to-low-end market is crowded with local participants, thus leading to fierce competition.
•Leading local companies have successfully built their brand reputation and are strengthening their research and development (R&D) capabilities to enter the high-end market by developing substitution devices at a lower cost to replace imported devices in some of the price-sensitive, lower-end hospitals. Some of them are trying to replicate the business models of multinational corporations to develop closed-end automatic analyzers of their own.
•Overall, the substitution devices developed by local companies are the most important factor in increasing the IVD market size, as it improves the accessibility of lower-level hospitals to advanced IVD technologies, thus boosting their need to update IVD products.

Past, Present, and Future IVD Market in China

Past 2000:
•Market size: $X million.
•Major market segments: Clinical chemistry, immunoassay, and hematology.
•Local manufacturers focus areas: Clinical chemistry, urine strips, and microplate enzyme immunoassay.
•Market domination: Multinational IVD companies.

Present 2011:
•Market size: $X million.
•Major market segments: Immunoassay, clinical chemistry, and SMBG.
•Local manufacturers focus areas: Immunoassay, clinical chemistry, and molecular testing, especially polymerase chain reaction (PCR) testing.

Future 2020:
•Market size: $Xmillion*.
•Major market segments: Immunoassay, SMBG, clinical chemistry, and molecular testing.
•Local manufacturers focus areas: Molecular testing, POCT, SMBG, immunoassay.
•Market domination: Multinational IVD companies and local companies share the market in most segments, despite the likelihood of foreign companies dominating the hematology, coagulation and microbiology segments.

Opportunities in Emerging Segments

Molecular Diagnostics
•Hepatitis, HIV, and HPV tests are expected to be the key growth drivers.
•Respiratory disease and sexually-transmitted disease testing generate the most revenue in the market.
•Opportunities are emerging in areas such as cancer testing and PCR blood bank.
•Chip-based tests and multiplexing tests are the topic of discussion in research.
•Fast molecular testing in microbiology is gaining focus.
End User
•The adoption level is low in hospitals of all sizes because of the high cost and low or no reimbursement.
•Low-throughput automated analyzers with minimal human interference can help penetrate the market better.

•Infectious disease testing is likely to become popular in the forecast period.
•Cardiac testing products are likely to become popular, as cardiac patient monitoring is very important in preventing a sudden onset of cardiac failure.
•Production standardization is needed.
•Immunochromotography-based tests are likely to dominate the market in the forecast period.
•Technology focused on enhancing the accuracy, sensitivity, and reliability of POCT testing could be the next trend.
End User
•Providing convenient monitoring and testing services in clinical centers in remote, rural areas would require robust POCT products.
•Rising disease prevention awareness among the Chinese is expected to boost demand for POCT products.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:


The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

2017 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • March 2017
  • by Venture Planning Group

This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...

IVD Market in BRIC by Product & Service, Technology, Application, Country - Forecast to 2022

  • $ 5650
  • Industry report
  • May 2017
  • by MarketsandMarkets

The IVD market in BRIC is expected to reach USD 15.71 billion by 2022 from USD 10.60 billion in 2017, at a CAGR of 8.2%. The key factors driving the growth of the market are growing patient awareness of ...

Microfluidics Market: Point of Care Testing Segment Anticipated to Register High Revenue Growth over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026

  • $ 5000
  • Industry report
  • February 2017
  • by Future Market Insight Global & Consulting Pvt Ltd

With 14.5% CAGR, point of care testing segment is the largest segment among the global microfluidics market application segments By the end of 2026, the point of care testing segment is projected to reach ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.